Skip to main content

National Influenza Vaccine Week targets those 'hesitant to vaccinate'

supply has caught up demand
supply has caught up demand
AP Photo/Jacques Brinon

Did you know that this week is National Influenza Vaccination Week?
To celebrate, the Ohio Department of Health put in yet another order for more H1N1 vaccine bringing Ohio’s total to 4,069,400 doses. According to their website one of the many targets for NIVW is to target those “hesitant about vaccination.”

Several governing bodies and health authorities seem concerned that the hysteria about H1N1 has died down, leaving room for additional outbreak.

This seems odd to some consumers as well as trained health practitioners, as the true impact of H1N1 has resulted in little more than a bad cold.
While true, as with any flu virus, death and complications have occurred, the numbers have not mirrored the near-hysteria seen this past fall.

The Numbers Don’t Add Up
While many were quick to diagnose H1N1, the only true way to confirm H1N1 is with a blood test. According to a report entitled H1N1 Flu Update: Surprising Numbers by Cincinnati Integrative Care Physician, Dr. Gary Huber, true H1N1 cases were vastly over reported.

In California of 13,704 blood specimens only 2% (296) tested positive for H1N1. Alaska had 722 blood specimens with 1% (11) testing positive for H1N1. Georgia screened 3,117 specimens and found just 2.4% testing positive for H1N1. So what did they have? Read Dr. Huber’s complete report here.

Another article by the Cincinnati-based Huber details even more damning conclusions with the widely-sought flu remedy, Tamiflu.

Even CDC officials acknowledged, in an October 60 Minutes appearance, that the risk of H1N1 complications being as severe as those portrayed on the evening news is probably less than 1/10th of 1%, leaving many to forgo the vaccine, opting to avoid any possible vaccine side effects.

All in all it appears that those ‘hesitant to vaccinate’ may be doing so for good reason.
 

Comments